MCU will be able to fund the Phase III MEND-CABG II study through to completion without a partnership but that should be the last option.
A partnership is absolutly necessary to start their phase 3 trials in MC-4232 and MC-1 for ACS. Does Medicure want to wait further 18-20 months with the advancement of these programs? I think not, that´s not acceptable!